ICEH
  • Home
    • About Us
    • Our Team
    • WHO Collaborating Centre
    • Impact
    • Partner Map
    • History
    • PhD Students
    • Our Supporters
    • External Advisory Panel
  • News
  • Research
    • Research Themes
    • All Publications
    • Lancet Commission on Global Eye Health
    • Rapid Assessment of Avoidable Blindness (RAAB)
  • Education
    • Master’s Course
    • Online Courses
    • Short course
    • Alumni Network
  • Journal
  • Capacity Strengthening
    • LINKS & Networks Programme
    • Commonwealth Eye Health Consortium (CEHC)
  • Peek
  • Webinars
    • Correcting Global Presbyopia: Webinar
    • Cataract: Global Data for 2030 Recordings
  • Donate
  • Contact
Select Page

Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial

by Hugh Bassett | Apr 28, 2023 | Publication

Globally, glaucomas are the most frequent cause of irreversible blindness, caused by a build-up of fluid in the eye. Africa has the highest prevalence of the condition and highest prevalence of blindness due to glaucoma. Rates in Sub-Saharan Africa are predicted to...

Effectiveness of an mHealth system on access to eye health services in Kenya: a cluster-randomised controlled trial

by Hugh Bassett | Jul 16, 2021 | Publication

A smartphone-based eye screening and referral system used by community members has been shown to almost triple the number of people with eye problems attending primary care, as well as increasing appropriate uptake of hospital services, compared to the standard...

Privacy

Accessibility

Cookies

Follow us:

  • Follow
  • Follow
  • Follow
an emblem of the WHO collaborating centre for eye care and vision
an emblem of the WHO collaborating centre for eye care and vision

Privacy

Accessibility

Cookies

Follow us:

  • Follow
  • Follow
  • Follow

We use cookies to help our website work properly, understand how it is used, and improve our content. Some cookies are essential, while analytics cookies are optional. Read our cookie policy.